Clinical Trial Update: AMG 827 in Subjects With Psoriatic Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial of AMG 827 in psoriatic arthritis was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• AMG 827

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Psoriatic Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2020-08-27